Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb 11:9:851949.
doi: 10.3389/fmed.2022.851949. eCollection 2022.

Editorial: Advances in Molecular Cytopathology

Elena Vigliar  1 , Maria D Lozano  2   3 , Sinchita Roy-Chowdhuri  4
Affiliations
Editorial

Editorial: Advances in Molecular Cytopathology

Elena Vigliar et al. Front Med (Lausanne). .
No abstract available

Keywords: digital pathology; epigenetic; molecular cytopathology; next generation sequencing; predictive immunohistochemistry.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Advances in Molecular Cytopathology

References

    1. Salto-Tellez M. More than a decade of molecular diagnostic cytopathology leading diagnostic and therapeutic decision-making. Arch Pathol Lab Med. (2018) 142:443–5. 10.5858/arpa.2017-0258-ED - DOI - PubMed
    1. Lindeman NI, Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker EH, et al. . Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. J Mol Diagn. (2018) 20:129–59. 10.5858/arpa.2017-0388-CP - DOI - PubMed
    1. Roy-Chowdhuri S, Mehrotra M, Bolivar AM, Kanagal-Shamanna R, Barkoh BA, Hannigan B, et al. . Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling. Mod Pathol. (2018) 31:1036–45. 10.1038/s41379-018-0006-x - DOI - PubMed
    1. FDA . Approval Timeline of Active Immunotherapies - Cancer Research Institute (CRI). Available online at: https://www.cancerresearch.org/scientists/immuno-oncology-landscape/fda-... (accessed January 4, 2022).
    1. Biswas S, Rao CM. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy. Eur J Pharmacol. (2018) 837:8–24. 10.1016/j.ejphar.2018.08.021 - DOI - PubMed

Publication types

LinkOut - more resources